Skip to main content
. 2021 May 14;7:104. doi: 10.1038/s41420-021-00485-1

Fig. 2. The potential mechanisms of breast cancer cells acquiring drug resistance revealed by the scRNA-seq.

Fig. 2

The pre-adapted and pre-existing resistant cells exist in the luminal breast cancer and TNBC respectively, and they are expanded contribute to drug resistance after endocrine therapy or chemotherapy.